Asia Vital Components Gelecekteki Büyüme

Future kriter kontrolleri 6/6

Asia Vital Components kazanç ve gelirin sırasıyla yıllık 30.2% ve 25.3% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 30.1% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 35.3% olacağı tahmin edilmektedir.

Anahtar bilgiler

30.2%

Kazanç büyüme oranı

30.1%

EPS büyüme oranı

Tech kazanç büyümesi	18.3%
Gelir büyüme oranı	25.3%
Gelecekteki özkaynak getirisi	35.3%
Analist kapsamı	Good
Son güncelleme	14 Nov 2024

Gelecekteki son büyüme güncellemeleri

Results: Asia Vital Components Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Nov 17

Analysts Are Updating Their Asia Vital Components Co., Ltd. (TWSE:3017) Estimates After Its First-Quarter Results

Aug 13

Asia Vital Components Co., Ltd. (TWSE:3017) Just Reported And Analysts Have Been Lifting Their Price Targets

Mar 17

Recent updates

Results: Asia Vital Components Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Nov 17

A Look At The Fair Value Of Asia Vital Components Co., Ltd. (TWSE:3017)

Nov 03

Asia Vital Components Co., Ltd. (TWSE:3017) Stocks Shoot Up 27% But Its P/E Still Looks Reasonable

Oct 18

Is Now The Time To Put Asia Vital Components (TWSE:3017) On Your Watchlist?

Oct 14

Is Asia Vital Components (TWSE:3017) A Risky Investment?

Sep 28

Analysts Are Updating Their Asia Vital Components Co., Ltd. (TWSE:3017) Estimates After Its First-Quarter Results

Aug 13

Asia Vital Components Co., Ltd.'s (TWSE:3017) Stock Retreats 30% But Earnings Haven't Escaped The Attention Of Investors

Aug 06

Is Asia Vital Components Co., Ltd. (TWSE:3017) Worth NT$634 Based On Its Intrinsic Value?

Jul 22

Asia Vital Components (TWSE:3017) Is Investing Its Capital With Increasing Efficiency

Jul 04

Asia Vital Components Co., Ltd.'s (TWSE:3017) P/E Is Still On The Mark Following 30% Share Price Bounce

May 29

Impressive Earnings May Not Tell The Whole Story For Asia Vital Components (TWSE:3017)

Mar 21

Asia Vital Components Co., Ltd. (TWSE:3017) Just Reported And Analysts Have Been Lifting Their Price Targets

Mar 17

Market Participants Recognise Asia Vital Components Co., Ltd.'s (TWSE:3017) Earnings Pushing Shares 29% Higher

Feb 26

Is Now The Time To Look At Buying Asia Vital Components Co., Ltd. (TPE:3017)?

Apr 23

Does Asia Vital Components (TPE:3017) Have A Healthy Balance Sheet?

Apr 08

Asia Vital Components Co., Ltd.'s (TPE:3017) Attractive Combination: Does It Earn A Place In Your Dividend Portfolio?

Mar 21

Will The ROCE Trend At Asia Vital Components (TPE:3017) Continue?

Feb 16

Asia Vital Components Co., Ltd.'s (TPE:3017) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

Feb 01

Did You Participate In Any Of Asia Vital Components' (TPE:3017) Fantastic 223% Return ?

Jan 17

Kazanç ve Gelir Büyüme Tahminleri

TWSE:3017 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (TWD Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
12/31/2026	115,928	14,593	14,511	14,953	7
12/31/2025	96,359	11,586	10,432	14,021	13
12/31/2024	71,310	8,337	6,535	10,050	10
9/30/2024	67,577	7,506	8,746	12,826	N/A
6/30/2024	64,281	6,608	10,463	13,535	N/A
3/31/2024	62,669	5,862	9,416	12,594	N/A
12/31/2023	59,194	5,305	6,556	10,324	N/A
9/30/2023	57,251	4,715	4,935	8,918	N/A
6/30/2023	56,365	4,528	3,682	8,120	N/A
3/31/2023	55,258	4,423	4,358	8,612	N/A
12/31/2022	56,017	4,162	5,135	8,840	N/A
9/30/2022	53,452	3,792	3,312	6,298	N/A
6/30/2022	50,342	3,407	2,133	4,482	N/A
3/31/2022	49,327	3,106	1,774	3,727	N/A
12/31/2021	47,333	2,901	1,213	2,841	N/A
9/30/2021	45,646	2,704	2,026	4,261	N/A
6/30/2021	43,922	2,490	2,364	4,768	N/A
3/31/2021	42,778	2,262	1,029	3,626	N/A
12/31/2020	39,666	1,916	2,404	4,870	N/A
9/30/2020	39,361	1,690	2,950	4,833	N/A
6/30/2020	39,228	1,308	1,491	3,318	N/A
3/31/2020	37,107	972	2,185	3,816	N/A
12/31/2019	36,534	958	757	2,458	N/A
9/30/2019	34,258	871	-648	971	N/A
6/30/2019	31,962	800	327	1,905	N/A
3/31/2019	29,482	747	274	1,719	N/A
12/31/2018	29,067	711	-723	971	N/A
9/30/2018	28,673	717	122	1,635	N/A
6/30/2018	27,873	776	N/A	940	N/A
3/31/2018	27,178	811	N/A	1,609	N/A
12/31/2017	27,109	887	N/A	1,806	N/A
9/30/2017	26,750	930	N/A	1,684	N/A
6/30/2017	26,496	898	N/A	1,961	N/A
3/31/2017	26,528	869	N/A	1,230	N/A
12/31/2016	26,504	860	N/A	2,154	N/A
9/30/2016	26,040	826	N/A	3,340	N/A
6/30/2016	26,312	829	N/A	3,133	N/A
3/31/2016	26,194	797	N/A	3,080	N/A
12/31/2015	25,675	741	N/A	2,493	N/A
9/30/2015	25,023	681	N/A	1,124	N/A
6/30/2015	24,317	822	N/A	1,898	N/A
3/31/2015	24,336	820	N/A	2,021	N/A
12/31/2014	24,047	729	N/A	1,962	N/A
9/30/2014	23,739	640	N/A	2,369	N/A
6/30/2014	22,767	355	N/A	913	N/A
3/31/2014	21,397	282	N/A	1,984	N/A
12/31/2013	19,990	246	N/A	1,505	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: 3017 'nin tahmini kazanç büyümesi (yıllık 30.2% ) tasarruf oranının ( 1.1% ) üzerindedir.

Kazançlar ve Piyasa: 3017 şirketinin kazançlarının (yıllık 30.2% ) TW pazarından (yıllık 19.4% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: 3017 şirketinin kazançlarının önümüzdeki 3 yıl içerisinde önemli ölçüde artması bekleniyor.

Gelir ve Pazar: 3017 şirketinin gelirinin (yıllık 25.3% ) TW pazarından (yıllık 12.7% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: 3017 şirketinin gelirinin (yıllık 25.3% ) yıllık 20% dan daha hızlı büyümesi öngörülüyor.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: 3017 'in Özsermaye Getirisi'nin 3 yıl içinde yüksek olması tahmin ediliyor ( 35.3 %)

Asia Vital Components Gelecekteki Büyüme

Future kriter kontrolleri 6/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Results: Asia Vital Components Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Analysts Are Updating Their Asia Vital Components Co., Ltd. (TWSE:3017) Estimates After Its First-Quarter Results

Price target increased by 8.6% to NT$824

Price target increased by 7.8% to NT$759

Price target increased by 7.1% to NT$735

Asia Vital Components Co., Ltd. (TWSE:3017) Just Reported And Analysts Have Been Lifting Their Price Targets

Recent updates

Results: Asia Vital Components Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Third quarter 2024 earnings: EPS and revenues exceed analyst expectations

A Look At The Fair Value Of Asia Vital Components Co., Ltd. (TWSE:3017)

Asia Vital Components Co., Ltd. (TWSE:3017) Stocks Shoot Up 27% But Its P/E Still Looks Reasonable

Is Now The Time To Put Asia Vital Components (TWSE:3017) On Your Watchlist?

Now 22% undervalued after recent price drop

Is Asia Vital Components (TWSE:3017) A Risky Investment?

Investor sentiment deteriorates as stock falls 16%

Now 20% undervalued after recent price drop

New major risk - Share price stability

Analysts Are Updating Their Asia Vital Components Co., Ltd. (TWSE:3017) Estimates After Its First-Quarter Results

Second quarter 2024 earnings released: EPS: NT$5.08 (vs NT$3.18 in 2Q 2023)

Upcoming dividend of NT$6.96 per share

Investor sentiment deteriorates as stock falls 18%

Asia Vital Components Co., Ltd.'s (TWSE:3017) Stock Retreats 30% But Earnings Haven't Escaped The Attention Of Investors

Asia Vital Components Co., Ltd. to Report Q2, 2024 Results on Aug 09, 2024

Now 28% overvalued

Is Asia Vital Components Co., Ltd. (TWSE:3017) Worth NT$634 Based On Its Intrinsic Value?

Asia Vital Components Co., Ltd. Announces the Changes of Representative of Juristic Person Director

Asia Vital Components (TWSE:3017) Is Investing Its Capital With Increasing Efficiency

Dividend increased to NT$7.00

Investor sentiment improves as stock rises 19%

Asia Vital Components Co., Ltd.'s (TWSE:3017) P/E Is Still On The Mark Following 30% Share Price Bounce

Price target increased by 8.6% to NT$824

Investor sentiment improves as stock rises 16%

We Think Asia Vital Components (TWSE:3017) Can Manage Its Debt With Ease

First quarter 2024 earnings: Revenues and EPS in line with analyst expectations

Asia Vital Components Co., Ltd. to Report Q1, 2024 Results on May 10, 2024

Now 20% overvalued after recent price rise

Price target increased by 7.8% to NT$759

Price target increased by 7.1% to NT$735

Do Asia Vital Components' (TWSE:3017) Earnings Warrant Your Attention?

Investor sentiment improves as stock rises 15%

A Look At The Intrinsic Value Of Asia Vital Components Co., Ltd. (TWSE:3017)

Now 20% overvalued after recent price rise

Impressive Earnings May Not Tell The Whole Story For Asia Vital Components (TWSE:3017)

Asia Vital Components Co., Ltd. (TWSE:3017) Just Reported And Analysts Have Been Lifting Their Price Targets

Asia Vital Components Co., Ltd., Annual General Meeting, Jun 14, 2024

Full year 2023 earnings: Revenues and EPS in line with analyst expectations

Now 28% overvalued after recent price rise

Price target increased by 8.3% to NT$506

Investor sentiment improves as stock rises 15%

Market Participants Recognise Asia Vital Components Co., Ltd.'s (TWSE:3017) Earnings Pushing Shares 29% Higher

Now 25% overvalued after recent price rise

Now 26% overvalued after recent price rise

Investor sentiment improves as stock rises 16%

New major risk - Share price stability

Now 24% undervalued after recent price drop

Price target increased by 14% to NT$427

Now 22% undervalued after recent price drop

Third quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Investor sentiment improves as stock rises 22%

Upcoming dividend of NT$5.00 per share at 1.5% yield

Investor sentiment improves as stock rises 15%

Asia Vital Components Co., Ltd. Announces Cash Dividend, Payable on September 20, 2023

Second quarter 2023 earnings released: EPS: NT$3.18 (vs NT$3.10 in 2Q 2022)

New major risk - Share price stability

Investor sentiment improves as stock rises 16%

Investor sentiment improves as stock rises 17%

Investor sentiment improves as stock rises 18%

First quarter 2023 earnings released: EPS: NT$2.85 (vs NT$2.11 in 1Q 2022)

Investor sentiment improves as stock rises 17%

Investor sentiment improves as stock rises 16%

Price target decreased by 13% to NT$108

Full year 2022 earnings released: EPS: NT$11.78 (vs NT$8.21 in FY 2021)

Price target decreased to NT$124

Third quarter 2022 earnings released: EPS: NT$3.51 (vs NT$2.42 in 3Q 2021)

Third quarter 2022 earnings released: EPS: NT$3.51 (vs NT$2.42 in 3Q 2021)

Upcoming dividend of NT$4.30 per share